Pittsburgh, PA, United States of America

Sami Saif Eldin Ali Osman

This inventor holds 1 USPTO granted patent. Top assignee: University of Pittsburgh. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sami Saif Eldin Ali Osman. Retrieved from https://idiyas.com/inventor/sami-saif-eldin-ali-osman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Sami Saif Eldin Ali Osman

Introduction

Sami Saif Eldin Ali Osman is an accomplished inventor based in Pittsburgh, PA. He has made significant contributions to the field of cancer research through his innovative work on antitumor compounds. His dedication to advancing medical science is evident in his patented inventions.

Latest Patents

Sami holds a patent for the "Synthesis of FR901464 and analogs with antitumor activity." This invention provides novel analogs of FR901464, along with an improved methodology for preparing these compounds. The compounds exhibit anti-cancer activity and are promising candidates for therapies targeting various disease states associated with dysfunctional RNA splicing. He has 1 patent to his name.

Career Highlights

Sami is affiliated with the University of Pittsburgh, where he conducts research and develops innovative solutions in the field of oncology. His work has garnered attention for its potential impact on cancer treatment and patient care.

Collaborations

Sami collaborates with Kazunori Koide, enhancing the research efforts in their shared field of study. Their partnership exemplifies the importance of teamwork in scientific advancements.

Conclusion

Sami Saif Eldin Ali Osman is a notable inventor whose work in synthesizing antitumor compounds holds great promise for future cancer therapies. His contributions to medical science are invaluable and reflect his commitment to improving health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…